News | Coronavirus (COVID-19) | April 17, 2020

OneOncology says clinical trial accruals increase in the face of COVID-19

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 OneOncology says clinical trial accruals increase in the face of COVID-19

April 17, 2020 — OneOncology, the national partnership of independent community oncologists, said today that enrolling patients in clinical trials at its partner practices has slightly increased in March and April just as the COVID-19 pandemic hit our communities hardest.

Clinical trial accruals in March and April have occurred at steady to slightly increased rate at OneOncology partner practices, while news outlets have reported that hundreds of clinical trials across the country have been suspended since March 1 because of the outbreak, especially at hospital-based settings, which are disproportionately impacted by the pandemic.   

"Elective medical procedures have stopped, but caring for cancer patients isn't elective," said Jeff Patton, M.D., OneOncology's acting CEO and president of physician services. "Not only do community oncology centers remain open providing patients life-saving treatments, we also continue to provide clinical trials at a steady to increased rate. Our centers are continuing to fulfill our collective mission."

When the Centers for Medicare and Medicaid (CMS) temporarily loosened its regulations to allow providers to be reimbursed for tele-health visits, the agency allowed researchers to keep some clinical trials open by evaluating and enrolling out-of-state patients.

"By loosening the regulations at both the federal and state levels, we were able to evaluate patients for eligibility in clinical trials that we otherwise couldn't because of state licensing requirements," said Natalie Dickson, M.D., chief medical officer at Tennessee Oncology and Chair of OneCouncil, the partnership's all-physician committee. "Now we're able to continue to provide access to these important clinical trials for new patients in other states."

OneOncology also cited that all 400 physicians at its partner practices are connected via a common technology platform, OneCommunity, as a reason for being able to enroll out of state patients efficiently for trials a physician otherwise might not know about.

"The physician to physician connectivity we're fostering through OneOncology is tremendous," said Lee Schwartzberg, M.D., OneOncology's chief medical officer. "From pathway development to getting patients enrolled into clinical trials as the pandemic continues, our physicians, researches and care teams' connection to each other and shared commitment to our patients is why our clinical trial initiatives can continue as trials in other healthcare settings are suspended."

For more information: http://www.oneoncology.com


Related Content

News | Prostate Cancer

September 26, 2022 — Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game ...

Time September 26, 2022
arrow
News | Women's Health

September 20, 2022 — Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast ...

Time September 20, 2022
arrow
News | Radiation Therapy

September 20, 2022 — UC San Diego Health is the first hospital system in San Diego to offer a new, highly targeted and ...

Time September 20, 2022
arrow
Feature | Lung Imaging | By Christine Book

“Lung cancer is the deadliest cancer in men and in women, and it all boils down to how it is detected and when it is ...

Time September 16, 2022
arrow
News | ASTRO

September 15, 2022 — On behalf of the nation's radiation oncologists and the more than one million people with cancer ...

Time September 15, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

September 15, 2022 — University of Minnesota Twin Cities scientists and engineers have found a way to improve the ...

Time September 15, 2022
arrow
News | Radiation Therapy

September 15, 2022 — The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering ...

Time September 15, 2022
arrow
News | Artificial Intelligence

September 14, 2022 — An AI tool is highly effective at detecting pancreatic cancer on CT, according to a study published ...

Time September 14, 2022
arrow
News | Treatment Planning

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized ...

Time September 12, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during ...

Time September 07, 2022
arrow
Subscribe Now